Ray Dalio
HCAT icon

Ray Dalio’s Health Catalyst HCAT Stock Holding History

Ray Dalio’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-107,217
Closed -$1.34M – 770
2023
Q2 		$1.34M Sell
107,217
-4,217
-4% -$50.2K 0.01% 534
2023
Q1 		$1.3M Sell
111,434
-932
-0.8% -$11.9K 0.01% 524
2022
Q4 		$1.19M Sell
112,366
-36,265
-24% -$350K 0.01% 623
2022
Q3 		$1.44M Sell
148,631
-2,477
-2% -$32.8K 0.01% 625
2022
Q2 		$2.19M Buy
151,108
+25,351
+20% +$432K 0.01% 667
2022
Q1 		$3.29M Buy
125,757
+31,662
+34% +$898K 0.01% 564
2021
Q4 		$3.73M Buy
94,095
+7,695
+9% +$351K 0.02% 357
2021
Q3 		$4.32M Buy
86,400
+6,181
+8% +$337K 0.02% 309
2021
Q2 		$4.45M Buy
+80,219
New +$4.27M 0.03% 352

Other funds holding HCAT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
DG
Daventry Group New York $87.8M AUM 3.83% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ray Dalio's HCAT Position: Q3 2023 in Review

Ray Dalio sold out of Health Catalyst (HCAT) in Q3 2023, closing a stake of 107,217 shares — an estimated $1.34M sold.

Ray Dalio first reported a position in HCAT in Q2 2021 and held it in 9 quarters. The position peaked at $4.45M in Q2 2021. 159 funds tracked by Wall St. Rank hold HCAT as of Q3 2023.

  • Ray Dalio reported no remaining Health Catalyst position as of Q3 2023 after selling out during the quarter.
  • Ray Dalio sold 107,217 Health Catalyst shares in Q3 2023, an estimated $1.34M.
  • Ray Dalio first reported a position in Health Catalyst in Q2 2021 and held it in 9 quarters.
  • Ray Dalio's Health Catalyst position peaked at $4.45M in Q2 2021.
  • 159 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2023.

Based on Bridgewater Associates's 13F filing for Q3 2023, filed 13 Nov 2023.